Feeling SAD? Here’s What You Need to Know

When the temperature and the time change, a type of depression called seasonal affective disorder (SAD) sets in for many people. But you don’t have to wait for the summer to stop feeling SAD. Read on to learn more about SAD and what you can do about it. What Is SAD? Seasonal affective disorder is a type […]

Severe Allergic Reactions at School: Are You Prepared?

For the 1 in 13 children who have food allergies, being prepared can make all the difference. Allergic reactions can be as mild as a rash or itchy skin, but some can be serious. An allergic reaction serious enough to be life-threatening is called as anaphylaxis. Anaphylaxis symptoms can develop quickly but may actually start […]

New Psoriasis Rx Gets Green Light

The US Food and Drug Administration (FDA) has approved a new plaque psoriasis drug. This new medication is found under the brand name Sotyktu. Its active ingredient is deucravacitinib. This drug is approved to treat adults with moderate to severe plaque psoriasis who will likely benefit from injection, pills or ultraviolet treatment. It hasn’t been […]

Long-Acting HIV Rx Approved

The US Food and Drug Administration (FDA) has approved a new medication to treat HIV. The FDA approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) to treat human immunodeficiency virus type 1 (HIV-1) infection. Cabenuva is the first FDA-approved HIV treatment that is injected only once per month. This long-acting medication is meant to replace daily pills for some patients. Currently, the […]

New Type of HIV Rx Approved

The US Food and Drug Administration (FDA) has approved a new type of HIV medication.   This new approval is for Rukobia (fostemsavir). The FDA approved it to treat adults who have HIV — specifically those who have already tried several HIV medications without success because they could not tolerate the side effects or there were resistance […]

Long-Acting HIV Rx Approved

The US Food and Drug Administration (FDA) has approved a new medication to treat HIV.   The FDA approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) to treat human immunodeficiency virus type 1 (HIV-1) infection. Cabenuva is the first FDA-approved HIV treatment that is injected only once per month. This long-acting medication is meant to replace daily pills for some patients. “Currently, […]